Bipolar disorder differences between genders: Special considerations for women

Women's Health

Volumn 7, Issue 6, 2011, Pages 663-676

  Vega, Patricia ^a   Barbeito, Sara ^a   Ruiz De Azúa, Sonia ^a   Martínez Cengotitabengoa, Mónica ^a   González Ortega, Itxaso ^a   Saenz, Margarita ^a   González Pinto, Ana ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

adherence; bipolar disorder; postpartum; pregnancy; women

Indexed keywords

ANTICONVULSIVE AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; CARBAMAZEPINE; CITALOPRAM; LAMOTRIGINE; LITHIUM; OLANZAPINE; ZIPRASIDONE;

ABSENCE OF SIDE EFFECTS; AGE DISTRIBUTION; ANXIETY DISORDER; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BIRTH DEFECT; BREAST FEEDING; CLINICAL FEATURE; COMORBIDITY; CONVULSION; DEPRESSION; DEVELOPMENTAL DISORDER; DRUG ABUSE; DRUG CONTRAINDICATION; DRUG SAFETY; EDUCATIONAL STATUS; ELECTROCONVULSIVE THERAPY; FEMALE; FETUS DISEASE; FETUS RISK; HIGH RISK PATIENT; HUMAN; INSOMNIA; LACTATION; MAJOR DEPRESSION; MANIA; NEUROLOGIC DISEASE; ONSET AGE; PATIENT COMPLIANCE; PREGNANCY; PREVALENCE; PUERPERIUM; RECURRENT DISEASE; RELAPSE; REVIEW; SEX DIFFERENCE; SYSTEMATIC REVIEW; TACHYCARDIA; TERATOGENICITY;

BIPOLAR DISORDER; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; POSTPARTUM PERIOD; PREGNANCY; SEX FACTORS;

EID: 80155150317     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/whe.11.71     Document Type: Review

References (85)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th Edition). American Psychiatric Press Inc., Washington, DC, USA (1994).
2. González-Pinto A, Gutierrez M, Mosquera F et al. First episode in bipolar disorder: misdiagnosis and psychotic symptoms. J. Affect. Disord. 50(1), 41-44 (1998). (Pubitemid 28338303)
3. González-Pinto A, van Os J, Peralta V et al. The role of age in the development of Schneiderian symptoms in patients with a first psychotic episode. Acta Psychiatr. Scand. 109(4), 264-268 (2004). (Pubitemid 38406707)
4. López P, Mosquera F, de León J et al. Suicide attempts in bipolar patients. J. Clin. Psychiatr. 62(12), 963-966 (2001). (Pubitemid 34007962)
5. González-Pinto A, Tohen M, Lalaguna B et al. Treatment of bipolar I rapid cycling patients during dysphoric mania with olanzapine. J. Clin. Psychopharmacol. 22(5), 450-454 (2002).
6. Cvetković-Bosnjak M. [Clinical characteristics of unipolar and bipolar depression] [Article in Croatian]. Med. Pregl. 51(7-8), 329-332 (1998).
7. Hendrick V, Altsuler LL, Gitlin MJ, Delrahim S, Hammen C. Gender and bipolar illness. J. Clin. Psychiatr. 61(5), 393-396 (2000). (Pubitemid 30345945)
8. Grunze H. The clinical side of bipolar disorders. Pharmacopsychiatry 44(Suppl. 1), S43-S48 (2011).
9. Angst J. The emerging epidemiology of hypomania and bipolar II disorder. J. Affect. Disord. 50(2-3), 143-151 (1998). (Pubitemid 28551784)
10. Miguel L, Roncero C, López-Ortiz C, Casas M. [Epidemiological and diagnostic axis I gender differences in dual diagnosis patients] [Article in Spanish]. Adicciones 23(2), 165-172 (2011).
11. Kawa I, Carter JD, Joyce PR et al. Gender differences in bipolar disorder: age at onset, course, comorbidity, and symptom presentation. Bipolar Disord. 7(2), 119-125 (2005). (Pubitemid 40439471)
12. Nivoli AM, Pacchiarotti I, Rosa AR et al. Gender differences in a cohort study of 604 bipolar patients: the role of predominant polarity. J. Affect. Disord. 133(3), 443-449 (2011).
13. Arnold LM. Gender differences in bipolar disorder. Psychiatr. Clin. N. Am. 26(3), 595-620 (2003). (Pubitemid 37175498)
14. Rasgon N, Bauer M, Grof P et al. Sex-specific self-reported mood changes by patients with bipolar disorder. J. Psychiatr. Res. 39(1), 77-83 (2005). (Pubitemid 39422287)
15. Zupancic ML. Role of atypical antipsychotics in rapid cycling bipolar disorder: a review of the literature. Ann. Clin. Psychiatr. 23(2), 141-149 (2011).
16. Rakofsky JJ, Dunlop BW. Treating nonspecific anxiety and anxiety disorders in patients with bipolar disorder: a review. J. Clin. Psychiatr. 72(1), 81-90 (2011).
17. Bowden CL. The role of ziprasidone in adjunctive use with lithium or valproate in maintenance treatment of bipolar disorder. Neuropsychiatr. Dis. Treat. 7, 87-92 (2011).
18. Altamura AC, Lietti L, Dobrea C, Benatti B, Arici C, DellOsso B. Mood stabilizers for patients with bipolar disorder: the state of the art. Exp. Rev. Neurother. 11(1), 85-99 (2011).
19. Li SC, Aggarwal SK. Estimation of resource utilization difference between lithium and valproate treatment groups from the VALID study. J. Med. Econ. 14(3), 350-356 (2011).
20. Kenna HA, Jiang B, Rasgon NL. Reproductive and metabolic abnormalities associated with bipolar disorder and its treatment. Harv. Rev. Psychiatr. 17(2), 138-146 (2009).
21. González-Pinto A, Mosquera F, Alonso M et al. Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment. Bipolar Disord. 8(5 Pt 2), 618-624 (2006). (Pubitemid 44567143)
22. González-Pinto A, Aldama A, González C, Mosquera F, Arrasate M, Vieta E. Predictors of suicide in first-episode affective and non-affective psychotic inpatients: five-year follow-up of patients from a catchment area in Vitoria, Spain. J. Clin. Psychiatr. 68(2), 242-247 (2007). (Pubitemid 46362645)
23. Keller MB, Lavori PW, Kane JM et al. Subsyndromal symptoms in bipolar disorder. A comparison of standard and low serum levels of lithium. Arch. Gen. Psychiatr. 49, 371-376 (1992).
24. Baldessarini RJ, Perry R, Pike J. Factors associated with treatment nonadherence among US bipolar disorder patients. Hum. Psychopharmacol. 23(2), 95-105 (2008). (Pubitemid 351359581)
25. Colom F, Vieta E, Martínez-Arán A, Reinares M, Benabarre A, Gasto C. Clinical factors associated with treatment noncompliance in euthymic bipolar patients. J. Clin. Psychiatr. 61, 549-555 (2000).
26. González-Pinto A, Lalaguna B, Mosquera F et al. Use of olanzapine in dysphoric mania. J. Affect. Disord. 66(2-3), 247-253 (2001). (Pubitemid 32907531)
27. Johnson RE, McFarland BH. Lithium use and discontinuation in a health maintenance organization. Am. J. Psychiatr. 153, 993-100 (1996).
28. González-Pinto A, Aldama A, Pinto AG et al. Dimensions of mania: differences between mixed and pure episodes. Eur. Psychiatr. 19(5), 307-310 (2004). (Pubitemid 38987844)
29. Vega P, Alonso M, Alberich S et al. Why do bipolar men not comply with treatment? The Spanish CIBERSAM data. Eur. J. Psychiatr. 23, 63-69 (2009
30. Sajatovic M, Bauer MS, Kilbourne AM, Vertrees JE, Williford W. Self-reported medication treatment adherence among veterans with bipolar disorder. Psychiatr. Serv. 57(1), 56-62 (2006). (Pubitemid 43053837)
31. Martínez-Aran A, Scott J, Colom F et al. Treatment nonadherence and neurocognitive impairment in bipolar disorder. J. Clin. Psychiatr. 70(7), 1017-1023 (2009).
32. Lang K, Korn J, Muser Choi JC, Abouzaid S, Menzin J. Predictors of medication nonadherence and hospitalization in Medicaid patients with bipolar I disorder given long-acting or oral antipsychotics. J. Med. Econ. 14(2), 217-226 (2011).
33. Kriegshauser K, Sajatovic M, Jenkins JH et al. Gender differences in subjective experience and treatment of bipolar disorder. J. Nerv. Ment. Dis. 198(5), 370-372 (2010).
34. Franzoi SL, Koehler V. Age and gender differences in body attitudes: a comparison of young and elderly adults. Int. J. Aging Hum. Dev. 47, 1-10 (1998). (Pubitemid 28378030)
35. Leskela U, Merlartin T, Rytsl H, Sokero P, Lestel-Mielonen P, Isomets E. The influence of major depressive disorder on objective and subjective social support: a prospective study. J. Nerv. Ment. Dis. 196, 876-883 (2008).
36. Payne JL, Roy PS, Murphy-Eberenz K et al. Reproductive cycle-associated mood symptoms in women with major depression and bipolar disorder. J. Affect. Disord. 99, 221-229 (2007). (Pubitemid 46275015)
37. Sharma V, Burt VK, Ritchie HL. Bipolar II postpartum depression: detection, diagnosis and treatment. Am. J. Psychiatr. 166(11), 1217-1221 (2009).
38. Heron J, Haque S, Ovebode F, Craddock N, Jones I. A longitudinal study of hypomania and depression symptoms in pregnancy and the postpartum period. Bipolar Disord. 11(4), 410-417 (2009).
39. Marangell LB. Current issues: women and bipolar disorder. Dialogues Clin. Neurosci. 10(2), 229-238 (2008). (Pubitemid 352028224)
40. Sharma V, Khan M, Corpse C, Sharma P. Missed bipolarity and psychiatric comorbidity in women with postpartum depression. Bipolar Disord. 10, 742-747 (2008).
41. Valentí M, Pacchiarotti I, Rosa AR et al. Bipolar mixed episodes and antidepressants: a cohort study of bipolar I disorder patients. Bipolar Disord. 13(2), 145-154 (2011).
42. Álamo C, Alonso Z, Álvarez I et al. Manejo de psicofámacos en situaciones vitales específicas. In:Manual de Psicofarmacología . Salazar M, Peralta C, Pastor FJ (Eds). Editorial Médica Panamericana, Madrid, Spain 87-92 (2011).
43. Einarson A, Boskovic R. Use and safety of antipsychotic drugs during pregnancy. J. Psychiatr. Pract. 15(3), 183-192 (2009).
44. ACOG Committee on Practice Bulletins - Obstetrics. ACOG Practice Bulletin: clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces Practice Bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactation. Obstet. Gynecol. 111(4), 1001-1020 (2008).
45. Peindl KS, Masand P, Mannelli P, Narasimham M, Patkar A. Polypharmacy in pregnant women with major psychiatric illness: a pilot study. J. Psychiatr. Pract. 13(6), 385-392 (2007). (Pubitemid 350158944)
46. Galbally M, Roberts M, Buist A. Perinatal psychotropic review group. Mood stabilizers in pregnancy: a systematic review. Aust. NZ J. Psychiatr. 44(11), 967-977 (2010).
47. Smith J, Whitehall J. Sodium valproate and the fetus: a case study and review of the literature. Neonatal Netw. 28(6), 363-367 (2009).
48. Berwaerts K, Sienaert P, De Fruyt J. [Teratogenic effects of lamotrigine in women with bipolar disorder] [Article in Dutch]. Tijdschr. Psychiatr. 51(10), 741-750 (2009).
49. Freeman MP, Gelenberg AJ. Bipolar disorder in women: reproductive events and treatment considerations. Acta Psychiatr. Scand. 112(2), 88-96 (2005).
50. McCauley-Elsom K, Gurvich C, Elsom SJ, Kulkarni J. Antipsychotics in pregnancy. J. Psychiatr. Ment. Health Nurs. 17(2), 97-104 (2010).
51. Holmes LB, Mittendorf R, Shen A, Smith CR, Hernandez-Diaz S. Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations. Arch. Neurol. DOI: 10.1001/archneurol.2011.133 (2011) (Epub ahead of print).
52. Newham JJ, Thomas SH, MacRitchie K, McElhatton PR, McAllister-Williams RH. Birth weight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study. Br. J. Psychiatr. 192(5), 333-337 (2008). (Pubitemid 351692376)
53. Gentile S. Prophylactic treatment of bipolar disorder in pregnancy and breastfeeding: focus on emerging mood stabilizers. Bipolar Disord. 8(3), 207-220 (2006).
54. Aichhorn W, Yazdi K, Kralovec K, Steiner H, Whitworth S, Stuppaeck C. Olanzapine plasma concentration in a newborn. J. Psychopharmacol. 22(8), 923-924 (2008).
55. Yeshayahu Y. The use of olanzapine in pregnancy and congenital cardiac and musculoskeletal abnormalities. Am. J. Psychiatr. 164(11), 1759-1760 (2007). (Pubitemid 350205358)
56. Mendhekar DN. Possible delayed speech acquisition with clozapine therapy during pregnancy and lactation. J. Neuropsychiatr. Clin. Neurosci. 19(2), 196-197 (2007). (Pubitemid 46649648)
57. Sethi S. Clozapine in pregnancy. Ind. J. Psychiatr. 48(3), 196-197 (2006).
58. Duran A, Ugur MM, Turan S, Emul M. Clozapine use in two women with schizophrenia during pregnancy. J. Psychopharmacol. 22(1), 111-113 (2008).
59. Dabbert D, Heinze M. Follow-up of a pregnancy with risperidone microspheres. Pharmacopsychiatry 39(6), 235 (2006). (Pubitemid 44899728)
60. Mendhekar D, Lohia D. Risperidone therapy in two successive pregnancies. J. Neuropsychiatr. Clin. Neurosci. 20(4), 485-486 (2008).
61. Rodriguez-Salgado B. Risperidone safety in pregnancy. A case report. Actas Esp. Psiquiatr. 36(6), 366-368 (2008).
62. Cabuk D, Savin A, Derinöz O, Biri A. Quetiapine use for the treatment of manic episode during pregnancy. Arch. Womens Ment. Health 10(5), 235-236 (2007). (Pubitemid 47493627)
63. Mendhekar DN, Sunder KR, Andrade C. Aripiprazole use in a pregnant schizoaffective woman. Bipolar Disord. 8(3), 299-300 (2006).
64. Peitl MV, Petrić D, Peitl V. Ziprasidone as a possible cause of cleft palate in a newborn. Psychiatr. Danub. 22(1), 117-119 (2010).
65. Werremeyer A. Ziprasidone and citalopram use in pregnancy and lactation in a woman with psychotic depression. Am. J. Psychiatr. 166(11), 1298 (2009).
66. Medrano J, Zardoya MJ, Pacheco L. Uso de ansiolíticos e hipnóticos en el embarazo. In:Uso de Psicofármacos en el Embarazo y Lactancia . Medrano J (Ed.). Euromedicine Ediciones Médicas SL, Badalona, Spain 47-58 (2009).
67. Altshuler LL, Cohen L, Szuba MP, Burt VK, Gitlin M, Mintz J. Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am. J. Psychiatr. 153(5), 592-606 (1996). (Pubitemid 26133611)
68. American Academy of Pediatrics Committee on Drugs. Use of psychoactive medication during pregnancy and possible effects on the fetus and newborn. Pediatrics 105, 880-887 (2000).
69. Rabheru K. The use of electroconvulsive therapy in special patient populations. Can. J. Psychiatr. 46(8), 710-719 (2001). (Pubitemid 33127086)
70. Prieto Martin RM, Palomero Rodriguez MA, de Miguel Fernandez P, Yusta Martin G, Alonso Borrego B, Muirel Villoria C. [Electroconvulsive therapy in the third trimester of pregnancy: a case report] [Article in Spanish]. Rev. Esp. Anestesiol. Reanim. 53(10), 653-656 (2006
71. Ceccaldi PF, Dubertret C, Keita H, Mandelbrot L. Use of sismotherapy during pregnancy for severe depression. Gynecol. Obstet. Fertil. 36(7-8), 773-775 (2008).
72. Ghanizadeh A, Ghanizadeh MJ, Moini R, Ekramzadeh S. Association of vaginal bleeding and electroconvulsive therapy use in pregnancy. J. Obstet. Gynaecol. Res. 35(3), 569-571 (2009).
73. Pesiridou A, Baquero G, Cristancho P et al. A case of delayed onset of threatened premature labor in association with electroconvulsive therapy in the third trimester of pregnancy. J. ECT 26(3), 228-230 (2010).
74. Salzbrenner S, Breeden A, Jarvis S, Rodriguez W. A 48-year-old woman primigravid via in vitro fertilization with severe bipolar depression and preeclampsia treated successfully with electroconvulsive therapy. J. ECT 27(1), e1-e3 (2011).
75. Rasmussen K. The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging (2nd edition). J. ECT 18(1), 58-59 (2002).
76. Anderson EL, Reti IM. ECT in pregnancy: a review of the literature from 1941 to 2007. Psychosom. Med. 71(2), 235-242 (2009).
77. Yonkers KA, Vigod S, Ross LE. Diagnosis, pathophysiology, and management of mood disorders in pregnant and postpartum women. Obstet. Gynecol. 117(4), 961-977 (2011).
78. Babu GN, Subbakrishna DK, Chandra PS. Prevalence and correlates of suicidality among Indian women with post-partum psychosis in an inpatient setting. Aust. NZ J. Psychiatr. 42(11), 976-980 (2008).
79. Liporace J, Kao A, DAbreu A. Concerns regarding lamotrigine and breast feeding. Epilepsy Behav. 5(1), 102-105 (2004). (Pubitemid 38937071)
80. Gentile S. Clinical utilization of atypical antipsychotics in pregnancy and lactation. Ann. Pharmacother. 38(7-8), 1265-1271 (2004). (Pubitemid 38802173)
81. Gentile S. Infant safety with antipsychotic therapy in breast-feeding: a systematic review. J. Clin. Psychiatr. 69(4), 666-673 (2008). (Pubitemid 351792344)
82. Munk-Olsen T, Laursen TM, Mendelson T, Pedersen CB, Mors O, Mortensen PB. Risks and predictors of readmission for a mental disorder during the postpartum period. Arch. Gen. Psychiatr. 66(2), 189-195 (2009).
83. Tohen M, Greenfield SF, Weiss RD, Zarate CA Jr, Vagge LM. The effect of comorbid substance use disorders on the course of bipolar disorder: a review. Harv. Rev. Psychiatr. 6(3), 133-141 (1998). (Pubitemid 28449160)
84. Gutierrez-Rojas L, Jurado D, Martínez-Ortega JM, Gurpegui M. Poor adherence to treatment associated with high recurrence in a bipolar disorder outpatient sample. J. Affect. Disord. 127, 77-83 (2010).
85. Del Bello MP, Hanseman D, Adler CM, Fleck DE, Strakowski SM. Twelve-month outcome of adolescents with bipolar disorder following first hospitalization for a manic or mixed episode. Am. J. Psychiatr. 164(4), 582-590 (2007 (Pubitemid 46650189)